Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia

19 Jan 2016

Abstract excerpt

The LIM domain only protein 2 (LMO2) is a key regulator of hematopoietic stem cell development. Expression of LMO2 has been evaluated in B-cell lymphoma, T-cell acute lymphoblastic leukemia and acute myeloid leukemia; however, information concerning its role in breakpoint cluster region/Abelson murine leukemia viral oncogene homolog 1 (BCR/ABL) negative B-cell acute lymphoblastic leukemia (B-ALL) remains limited....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26998100
DOI: 10.3892/ol.2016.4127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemiaPMID 26998100Read ↗

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcomeSemantic proximity Read ↗

HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias.Semantic proximity Read ↗

LMO2 at 25 years: a paradigm of chromosomal translocation proteinsSemantic proximity Read ↗

LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.Semantic proximity Read ↗

Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALLSemantic proximity Read ↗

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphomaSemantic proximity Read ↗

A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patientsSemantic proximity Read ↗

A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.Semantic proximity Read ↗

LIM Domain Only-2 (LMO2) Induces T-Cell Leukemia by Two Distinct PathwaysSemantic proximity Read ↗

LMO3 Interacts with Neuronal Transcription Factor, HEN2, and Acts as an Oncogene in NeuroblastomaSemantic proximity Read ↗

The LIM domain gene <i>LMO4</i> inhibits differentiation of mammary epithelial cells <i>in vitro</i> and is overexpressed in breast cancerSemantic proximity Read ↗

The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.